LOXL2 and hepatocellular carcinoma: The overexpression of LOXL2 played a tumor‐promoting role and indicated poor prognosis in esophageal squamous cell carcinoma,16 hepatocellular carcinoma,44, 45 lung carcinoma,17 gastric carcinoma,46 and breast carcinoma.47, 48